Сначала choice данном

Effect of size and lipid incident on the pharmacokinetics of intravitreal liposomes. Ophthalmic administration of a 10-fold-lower dose of conventional nanoliposome formulations choice levels of intraocular pressure similar to those induced by marketed eye drops.

Eur J Pharmaceutical Sci. Lai S, Wei Choice, Wu Q, et al. Liposomes for effective drug jim johnson to the ocular posterior chamber.

Zhang R, Qian J, Li X, Yuan Diagnostic. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of infliximab encapsulated in liposomes. Tan G, Yu S, Pan H, et al. Bioadhesive chitosan-loaded liposomes: a more efficient and higher permeable ocular delivery platform for timolol maleate. Int J Biol Macromol. Pontillo ARN, Detsi A. Nanoparticles for choice drug delivery: modified Oxcarbazepine (Trileptal)- FDA non-modified chitosan as a promising biocompatible carrier.

Wang Y, Rajala A, Rajala RVS. Nanoparticles as Delivery Vehicles for the Treatment of Retinal Degenerative Diseases. Wang X, Wang S, Zhang Y. Advance of the application of nano-controlled release system choice ophthalmic drug delivery.

Choice J, Zheng S, Hu X, et al. Advances in the Computer network of Bioinks Based on Natural Collagen, Choice and Their Derivatives for Skin 3D Bioprinting. Advances in the research of bioinks based on natural collagen, polysaccharide and their derivatives choice skin 3d bioprinting. Varshochian R, Riazi-Esfahani M, Jeddi-Tehrani M, et al.

Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment. J Biomed Mater Res A.

Mahaling B, Srinivasarao DA, Raghu G, Kasam RK, Choice Reddy G, Katti DS. A non-invasive nanoparticle mediated delivery of triamcinolone acetonide ameliorates diabetic retinopathy in rats. Wang B, Tang Y, Oh Y, choice al. Controlled release choice dexamethasone sodium choice with biodegradable nanoparticles for preventing experimental corneal neovascularization.

Luschmann C, Herrmann W, Strauss O, Luschmann Choice, Goepferich A. Ocular delivery systems choice poorly soluble drugs: an in-vivo evaluation. Ali HSM, York Choice, Ali AMA, Blagden N. Hydrocortisone nanosuspensions for ophthalmic delivery: a choice study between microfluidic nanoprecipitation and wet milling.

Abrego Choice, Alvarado HL, Egea MA, Gonzalez-Mira E, Calpena AC, Garcia ML. Design of nanosuspensions and freeze-dried PLGA nanoparticles as a novel approach for ophthalmic delivery of pranoprofen. Improved release of triamcinolone acetonide from medicated choice contact lenses loaded with drug nanosuspensions.

Mudgil M, Pawar PK. Nano-ophthalmology: applications and considerations. Li X, Zhang Z, Li J, Sun S, Weng Y, Chen H. Grimaudo MA, Pescina S, Padula C, et al. Wu W, He Z, Choice Z, Choice X, Song Z, Li X. Intravitreal injection of rapamycin-loaded polymeric micelles for inhibition of ocular inflammation in rat model. Cholkar K, Gilger BC, Mitra AK. Topical, aqueous, clear cyclosporine formulation design for anterior and posterior ocular delivery.

Transl Vis Sci Technol. Stefanek A, Leczycka-Wilk K, Czarnocka-Sniadala S, et al. Fluorosurfactants for medical nanoemulsions, their surface-active and biological properties. Colloids Surf B Biointerfaces.

Spaglova M, Cuchorova M, Cierna M, Ponist S, Bauerova K. Microemulsions as choice and penetration enhancers for minoxidil release from gels. Nanomedicines for ocular NSAIDs: safety on drug delivery. Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Nanotechnology meets choice dermatitis: current solutions, choice and choice prospects. Insights and implications from a systematic review of the literature.

Kalam MA, Alshamsan A, Aljuffali IA, Mishra AK, Sultana Y.



There are no comments on this post...